|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 35/00 | |
| A61K 31/455 | |||
| A61K 38/06 | |||
| A61K 31/285 | |||
| A61K 31/60 |
| (11) | Number of the document | 2321012 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09808635.8 |
| Date of filing the European patent application | 2009-08-14 | |
| (97) | Date of publication of the European application | 2011-05-18 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/053858 |
| Date | 2009-08-14 |
| (87) | Number | WO 2010/021928 |
| Date | 2010-02-25 |
| (30) | Number | Date | Country code |
| 189511 P | 2008-08-20 | US |
| (72) |
SCHWARTZ, Brian, Eric, US
LEWIS, Jonathan, US
KOMARNITSKY, Philip, B., US
|
| (73) |
Solasia Pharma K.K.,
4F, Sumitomo Fudosan Shiba-koen Tower 2-11-1 Shiba-koen Minato-ku, Tokyo 105-0011,
JP
|
| (54) | ORGANOARSENIC COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER |
| ORGANOARSENIC COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER |